Evidence map›Paper›PMID 36217211›Full record

ArticleAlzheimer's research & therapy2022

Altered basal forebrain function during whole-brain network activity at pre- and early-plaque stages of Alzheimer's disease in TgF344-AD rats.

Monica van den Berg, Mohit H Adhikari, Marlies Verschuuren, Isabel Pintelon, Tamara Vasilkovska, Johan Van Audekerke, Stephan Missault, Loran Heymans, Peter Ponsaerts, Winnok H De Vos and 3 more

Open access · goldAbstract read
In one paragraph

Article in Alzheimer's research & therapy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Monica van den BergBio-Imaging Lab, University of Antwerp, Universiteitsplein 1 2610 Wilrijk, Antwerp, Belgium. monica.vandenberg@uantwerpen.be.
Mohit H AdhikariBio-Imaging Lab, University of Antwerp, Universiteitsplein 1 2610 Wilrijk, Antwerp, Belgium.
Marlies VerschuurenµNEURO Research Centre of Excellence, University of Antwerp, Antwerp, Belgium.
Isabel PintelonµNEURO Research Centre of Excellence, University of Antwerp, Antwerp, Belgium.
Tamara VasilkovskaBio-Imaging Lab, University of Antwerp, Universiteitsplein 1 2610 Wilrijk, Antwerp, Belgium.
Johan Van AudekerkeBio-Imaging Lab, University of Antwerp, Universiteitsplein 1 2610 Wilrijk, Antwerp, Belgium.
Stephan MissaultBio-Imaging Lab, University of Antwerp, Universiteitsplein 1 2610 Wilrijk, Antwerp, Belgium.
Loran HeymansBio-Imaging Lab, University of Antwerp, Universiteitsplein 1 2610 Wilrijk, Antwerp, Belgium.
Peter PonsaertsLaboratory of Experimental Hematology, Vaccine and Infectious Disease Institute (Vaxinfectio), University of Antwerp, Universiteitsplein 1, 2610, Wilrijk, Antwerp, Belgium.
Winnok H De VosµNEURO Research Centre of Excellence, University of Antwerp, Antwerp, Belgium.
Annemie Van der LindenBio-Imaging Lab, University of Antwerp, Universiteitsplein 1 2610 Wilrijk, Antwerp, Belgium.
Georgios A Keliris *Bio-Imaging Lab, University of Antwerp, Universiteitsplein 1 2610 Wilrijk, Antwerp, Belgium. gkeliris@ics.forth.gr.
Marleen Verhoye *Bio-Imaging Lab, University of Antwerp, Universiteitsplein 1 2610 Wilrijk, Antwerp, Belgium. Marleen.Verhoye@uantwerpen.be.
University of Antwerp · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundImbalanced synaptic transmission appears to be an early driver in Alzheimer's disease (AD) leading to brain network alterations. Early detection of altered synaptic transmission and insight into mechanisms causing early synaptic alterations would be valuable treatment strategies. This study aimed to investigate how whole-brain networks are influenced at pre- and early-plague stages of AD and if these manifestations are associated with concomitant cellular and synaptic deficits. 

methodsTo this end, we used an established AD rat model (TgF344-AD) and employed resting state functional MRI and quasi-periodic pattern (QPP) analysis, a method to detect recurrent spatiotemporal motifs of brain activity, in parallel with state-of-the-art immunohistochemistry in selected brain regions.

resultsAt the pre-plaque stage, QPPs in TgF344-AD rats showed decreased activity of the basal forebrain (BFB) and the default mode-like network. Histological analyses revealed increased astrocyte abundance restricted to the BFB, in the absence of amyloid plaques, tauopathy, and alterations in a number of cholinergic, gaba-ergic, and glutamatergic synapses. During the early-plaque stage, when mild amyloid-beta (Aβ) accumulation was observed in the cortex and hippocampus, QPPs in the TgF344-AD rats normalized suggesting the activation of compensatory mechanisms during this early disease progression period. Interestingly, astrogliosis observed in the BFB at the pre-plaque stage was absent at the early-plaque stage. Moreover, altered excitatory/inhibitory balance was observed in cortical regions belonging to the default mode-like network. In wild-type rats, at both time points, peak activity in the BFB preceded peak activity in other brain regions-indicating its modulatory role during QPPs. However, this pattern was eliminated in TgF344-AD suggesting that alterations in BFB-directed neuromodulation have a pronounced impact in network function in AD.

conclusionsThis study demonstrates the value of rsfMRI and advanced network analysis methods to detect early alterations in BFB function in AD, which could aid early diagnosis and intervention in AD. Restoring the global synaptic transmission, possibly by modulating astrogliosis in the BFB, might be a promising therapeutic strategy to restore brain network function and delay the onset of symptoms in AD.

Indexed as

Alzheimer DiseaseBasal ForebrainAmyloid beta-PeptidesAnimalsCholinergic AgentsDisease Models, Animalgamma-Aminobutyric AcidGliosisPlaque, AmyloidRatsRats, Inbred F344Rats, TransgenicAmyloid beta-PeptidesCholinergic Agentsgamma-Aminobutyric AcidAlzheimer’s diseaseAmyloidBasal forebrainGliosisNetwork dysfunctionQuasi-periodic patternsResting state functional MRISynaptic dysfunction

Identifiers

PMID36217211
PMCPMC9549630
OpenAlexW4304140827

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.